Navigation Links
Angiotech to Establish Separate Operating and Royalty Businesses
Date:7/7/2008

ies a total equity

value for API of $625 million, assuming $75 million in cash and cash

equivalents at API at closing and no debt, other than the guarantees

of the remaining amounts of Angiotech's two existing debt issues. The

proposed transaction at this value enables Angiotech to raise a

significant amount of capital to address the Company's current

capital structure issues with more limited dilution than would likely

be possible if Angiotech were to attempt to raise similar amounts of

capital using security structures available to Angiotech on a

consolidated basis.

- Flexible transaction size to optimize use of capital. Angiotech

expects to raise a minimum of US$200 million in gross proceeds

through this transaction. Depending upon the interest level in the

contemplated tender offers for Angiotech's two outstanding debt

issues, the Company may elect to raise up to US$300 million. This

transaction structure allows Angiotech the flexibility to elect to

raise a variable amount of capital, at the Company's option,

depending on the expected cost of retiring selected amounts of each

outstanding debt issue.

- Align capitalization with business risk, strategy and structures. By

forming and capitalizing API, Angiotech has established a plan to

achieve a more equity oriented capital structure for its operating

businesses, more consistent with its original strategy and with peer

companies in the life sciences industry. With the opportunity to

pursue an initial public offering of API in the future, or other

financial and strategic alternatives together with Ares and New Leaf,

API will have improved financial flexibility, enabling API to better

capitalize on its various business and product development


'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
11. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2015)... May 19, 2015 Research and Markets ... "Global Cell Therapy Market Outlook 2020 " ... therapy in tissue and regenerative medicine is expected to ... options which could help in the growth of deregulated ... but they are unable to form new tissue or ...
(Date:5/20/2015)... 20, 2015 The global genotyping market ... during the forecast period of 2015 to 2020 to ... used in drug discovery and development process and to ... In addition to this,heavy investments by key manufacturers to ... also propelling market growth. Browse 113 market data tables ...
(Date:5/20/2015)... Westport, CT (PRWEB) May 20, 2015 ... the 10th anniversary of its acquisition of Tiger-Sul. ... from Enersul (Calgary Alberta, Canada) in May 2005, H.J. ... line to build it into a comprehensive portfolio of ... the strength of H.J. Baker and the innovation of ...
(Date:5/20/2015)... 20, 2015  Haemonetics Corporation (NYSE: HAE ) ... CEO, will present at The Jefferies 2015 Global Healthcare ... June 1 st , 2015 at 8:30am Eastern time.  ... presentation live via webcast at: http://wsw.com/webcast/jeff88/hae ... HAE ) is a global healthcare company dedicated to ...
Breaking Biology Technology:Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 3Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 2Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 3Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 4Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 5Agricultural Firm H.J. Baker & Bro., Inc., Celebrates 10 Years Since Acquisition Of Tiger-Sul 2Agricultural Firm H.J. Baker & Bro., Inc., Celebrates 10 Years Since Acquisition Of Tiger-Sul 3
... 11, 2011 The American College of Medical Genetics ... Online Live Learning Center , which will bring online ... This valuable, on-demand resource brings the latest educational programming ... such as the Genetics Review Course and Annual Meeting ...
... the Simple Platform for Learning, is a low-cost ... , eLearning and classroom management. ... educators spend a great deal of time and effort ... that want a system that is easy to use, ...
... YORK, Aug. 11, 2011 Bion Environmental Technologies, Inc. ... notified by the United States Patent and Trademark Office ... Organisms" has been granted.  The new ... nutrient uptake capabilities with respect to the removal of ...
Cached Biology Technology:ACMG Announces New Online Live Learning Center: Will Bring Genetics and Genomics Education to Varied Health Professionals 2The SimPL Learning Management System Supports Compliance in Healthcare Facilities 2Bion Announces New U.S. Patent for Phosphorus Removal 2
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, ... the start of a new Phase III double blind, ... its novel formulation, CM-AT, on all children ages 3-8 ... its FDA Phase III double blinded clinical trial for ... low levels of the digestive enzyme chymotrypsin. This new ...
(Date:5/7/2015)... GOTHENBURG, Sweden , May 7, 2015 /PRNewswire/ ... new touch fingerprint sensors, FPC1022 and FPC1035, FPC,s ... FPC1022 and FPC1035 are mainly considered for integration ... decreased size gives smartphone OEMs increased possibilities to ... portfolio. The decreased size also improves possibilities for ...
(Date:4/27/2015)... more than four decades, AUVSI,s Unmanned Systems ... event for the unmanned land, sea, and air industries. ... local, national, or trade news organization interested in gathering ... applications of unmanned technologies. The conference will explore the ... and how it will soon impact the lives of ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5
... a major expansion of a lingua franca used ... organisms. The expansion provides terms that scientists ... occur when a pathogenic or beneficial microbe encounters ... developing new interventions for preventing infections by disease-causing ...
... the University of York has been awarded a Research ... Trust to study the geometry of viruses. , Dr ... Biology and Mathematics, will study the structure and assembly ... strategies. , Viruses have highly symmetrical external ...
... Researchers have long said they won't be able to understand ... ?a map of how billions of neurons are interconnected. Now, ... what many believe to be a major hurdle to preparing ... neuron. , In the March 1 issue of the journal ...
Cached Biology News:Uniform language for describing genes of pathogenic and beneficial microbes 2Uniform language for describing genes of pathogenic and beneficial microbes 3York mathematician probes geometric route to combat viruses 2Deconstructing brain wiring, one neuron at a time 2Deconstructing brain wiring, one neuron at a time 3
... High Five cells (BTI-TN-5B1-4) derived ... have been shown to be capable ... secreted recombinant proteins compared to other ... the following features:- -Rapid doubling time as ...
... Flipper® Racks are ideal for storage and ... These polypropylene racks withstand extreme temperatures, making ... They may also be autoclaved for use ... one side accommodates 0.5ml microcentrifuge tubes, the ...
... comprehensive, cost-effective solution to your TechMate ... quality into both our products and ... chemistries and antibodies that have been ... also includes our competitively priced accessories ...
... consists of universal lysis buffer, PCR mix, ... 100 25 l volume PCR reactions. This ... negative or positive rod and coccus bacteria, ... Cereus, Staphylococcus Aureus, Streptococcus Agalactiae, and etc. ...
Biology Products: